Pensionfund Sabic’s Vertex Pharmaceuticals VRTX Stock Holding History

Pensionfund Sabic’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,000	Closed	-$2.11M	–	202
2023 Q2	$2.11M	Hold	6,000	–	–	0.71%	30
2023 Q1	$1.89M	Sell	6,000 -1,500	-20%	-$450K	0.66%	39
2022 Q4	$2.17M	Hold	7,500	–	–	0.7%	37
2022 Q3	$2.17M	Hold	7,500	–	–	0.77%	26
2022 Q2	$2.11M	Sell	7,500 -1,000	-12%	-$268K	0.68%	37
2022 Q1	$2.22M	Sell	8,500 -3,000	-26%	-$712K	0.55%	53
2021 Q4	$2.52M	Buy	+11,500	New	+$2.24M	0.47%	88

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pensionfund Sabic's VRTX Position: Q3 2023 in Review

Pensionfund Sabic sold out of Vertex Pharmaceuticals (VRTX) in Q3 2023, closing a stake of 6,000 shares — an estimated $2.11M sold.

Pensionfund Sabic first reported a position in VRTX in Q4 2021 and held it in 7 quarters. The position peaked at $2.52M in Q4 2021. 1,277 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.

Pensionfund Sabic reported no remaining Vertex Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Pensionfund Sabic sold 6,000 Vertex Pharmaceuticals shares in Q3 2023, an estimated $2.11M.
Pensionfund Sabic first reported a position in Vertex Pharmaceuticals in Q4 2021 and held it in 7 quarters.
Pensionfund Sabic's Vertex Pharmaceuticals position peaked at $2.52M in Q4 2021.
1,277 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.

Based on Pensionfund Sabic's 13F filing for Q3 2023, filed 10 Oct 2023.